336 related articles for article (PubMed ID: 23070984)
41. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
Konno T; Nagata Y; Teramoto R; Fujino N; Nomura A; Tada H; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M; Hayashi K
Am J Cardiol; 2016 Feb; 117(3):443-9. PubMed ID: 26705881
[TBL] [Abstract][Full Text] [Related]
42. Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias.
Fujita T; Konno T; Yokawa J; Masuta E; Nagata Y; Fujino N; Funada A; Hodatsu A; Kawashiri MA; Yamagishi M; Hayashi K
J Cardiol; 2015 Jul; 66(1):63-8. PubMed ID: 25458192
[TBL] [Abstract][Full Text] [Related]
43. Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.
Raman B; Ariga R; Spartera M; Sivalokanathan S; Chan K; Dass S; Petersen SE; Daniels MJ; Francis J; Smillie R; Lewandowski AJ; Ohuma EO; Rodgers C; Kramer CM; Mahmod M; Watkins H; Neubauer S
Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):157-167. PubMed ID: 30358845
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
[TBL] [Abstract][Full Text] [Related]
45. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
46. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
47. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
48. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
[TBL] [Abstract][Full Text] [Related]
49. Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy.
Liu J; Zhao S; Yu S; Wu G; Wang D; Liu L; Song J; Zhu Y; Kang L; Wang J; Song L
Radiology; 2022 Feb; 302(2):298-306. PubMed ID: 34726536
[TBL] [Abstract][Full Text] [Related]
50. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy.
Todiere G; Aquaro GD; Piaggi P; Formisano F; Barison A; Masci PG; Strata E; Bacigalupo L; Marzilli M; Pingitore A; Lombardi M
J Am Coll Cardiol; 2012 Sep; 60(10):922-9. PubMed ID: 22935464
[TBL] [Abstract][Full Text] [Related]
51. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis.
Hoffmann R; Altiok E; Friedman Z; Becker M; Frick M
Am J Cardiol; 2014 Oct; 114(7):1083-8. PubMed ID: 25212549
[TBL] [Abstract][Full Text] [Related]
52. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
53. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
[TBL] [Abstract][Full Text] [Related]
55. Notched QRS for the assessment of myocardial fibrosis in hypertrophic cardiomyopathy.
Kawasaki T; Harimoto K; Honda S; Sato Y; Yamano M; Miki S; Kamitani T
Circ J; 2015; 79(4):847-53. PubMed ID: 25739570
[TBL] [Abstract][Full Text] [Related]
56. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
[TBL] [Abstract][Full Text] [Related]
57. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
58. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
[TBL] [Abstract][Full Text] [Related]
59. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
[TBL] [Abstract][Full Text] [Related]
60. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; DaniĆowicz-Szymanowicz L
J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]